Sorry, this entry is only available in Ukrainian.
Імуносупресанти додано до переліку лікарських засобів, які підлягають реімбурсації
Вас может заинтересовать:
WEB only
On July 26, 2023, FDA released a guidance document on a program at FDA’s Center for Drug Evaluation and Research (CDER) to publicize a listing of accepted voluntary consensus standards…
WEB only
To provide continuous support to Ukrainian research, the Commission has tripled the initial budget of the EURIZON Fellowship Programme to €4.5 million under Horizon Europe. Russia's invasion of Ukraine has…
